At-home testing company Everlywell acquires telehealth business
After a busy year, at-home testing company Everlywell is growing through two acquisitions. It bought telehealth practice PWNHealth and another at-home lab testing company.
Everlywell gets green light to sell at-home Covid-19 test kit without prescription
After Everlywell received an emergency use authorization last year from the FDA for its at-home collection kit, the agency gave Everlywell the green light to sell its test kits without requiring a prescription.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Demand for at-home testing propels Everlywell to $175M in new funding
The Austin-based startup has distributed more than 500,000 Covid-19 test kits to date, and expects total sales to quadruple by the end of the year.
Some startups grapple with USPS delays in medication delivery
Some healthcare startups that offer at-home prescription deliveries and test kits have experienced delays with the USPS. They shared how they're navigating the changes.
Startups pause at-home tests after new FDA guidance
Everlywell, Nurx, and a bevy of other companies had begun marketing at-home tests as the U.S. still faces a shortage. But they had to stop after the Food and Drug Administration clarified that it had not approved at-home testing.
FDA warns against at-home Covid-19 tests
The Food and Drug Administration updated its guidance to note that it has not approved any at-home tests for Covid-19. A number of startups began offering private tests, for a cost, after a public shortage of testing has left many with symptoms searching for solutions.
presented by
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Direct-to-consumer lab testing startup EverlyWell raises $50 million
CEO and founder Julia Cheek started EverlyWell after her own experiences trying to diagnose her own health issues highlighted problems of cost and convenience in the traditional lab testing process.
EverlyWell CEO shares plans for the $1M deal she secured on Shark Tank
Julia Cheek said she admires what 23andMe has built and has big ambitions for her own consumer testing business.
EverlyWell garners $2M to add more tests, staff for diagnostic testing startup
Julia Cheek, EverlyWell CEO and cofounder, said in an email that the funding will help the company expand its suite of tests, hire key leadership positions, launch new partnerships and enhance product features this year.
Startup EverlyWell launches three at-home diagnostic tests
An Austin, Texas-based startup is hoping to capitalize on a gap in the home lab test market by offering three new diagnostic tests, each for less than $100.
Maximize Revenue and Patient Care with Strategic Weight Loss Management
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.